Transfusion Medicine Disorders

Transfusion Medicine Disorders refer to a group of conditions and complications associated with the collection, testing, storage, and transfusion of blood and blood components. Blood transfusions are life-saving procedures used to treat severe blood loss, anaemia, clotting disorders, and various haematological conditions. However, adverse reactions can occasionally occur despite rigorous safety measures. These disorders include acute and delayed haemolytic transfusion reactions, febrile non-haemolytic reactions, allergic reactions, transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), and transfusion-transmitted infections. Careful blood group matching, antibody screening, and donor testing significantly reduce these risks.

Patients receiving repeated transfusions, such as those with thalassaemia or sickle cell disease, may develop iron overload or alloimmunisation, making future transfusions more challenging. Prompt recognition of symptoms including fever, chills, breathlessness, rash, chest pain, or dark urine during or after transfusion is essential for immediate treatment. Modern transfusion medicine emphasises strict compatibility testing, infection screening, leukocyte reduction, and evidence-based transfusion practices to maximise patient safety.

Continuous monitoring, appropriate blood component selection, and adherence to established transfusion protocols help minimise complications. Early diagnosis and expert management ensure that blood transfusions remain a safe, effective, and essential therapy for patients requiring life-saving blood replacement or specialised blood component support.